Tag: US Foreign Policy

  • Gilead’s Lenacapavir to Reach High-Burden Nations ‘At Cost’

    The US government and Gilead Sciences have announced a landmark plan to supply the long-acting HIV prevention drug, lenacapavir, at cost to high-burden countries. This initiative aims to protect 2 million people via PEPFAR and The Global Fund. In a major step forward for global public health, the United States State Department announced a groundbreaking plan on Thursday. The aim…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • PEPFAR Funding Secure for Vital HIV Programmes

    The United States Congress has spared the President’s Emergency Plan for AIDS Relief (PEPFAR), a cornerstone of global HIV/AIDS prevention for nearly two decades, from a potential $400 million budget cut.. The proposed reduction was part of the Trump administration’s wider “rescissions package.” This package aimed at clawing back $9.4 billion in previously approved federal spending. However, lawmakers raised significant…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • USAID Funding Cuts Could Trigger 14 Million Deaths by 2030

    Deep and ongoing USAID funding cuts to the US Agency for International Development (USAID), coupled with its potential dismantling, could result in more than 14 million additional deaths across the globe by 2030. This is according to new research. The study, published in the prestigious medical journal The Lancet on Monday, 30 June, highlights the catastrophic human cost of the…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Global Health: Understanding the WHO Pandemic Accord

    In a significant move for global health, the World Health Organisation (WHO) has adopted a new legally binding agreement. This is to bolster international preparedness for future pandemics. The World Health Assembly passed the accord in Geneva after three years of intense negotiations. It was met with applause from member countries. However, the absence of the United States, the WHO’s…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in